Tokyo Electric Power Company has suspended the first attempt to extract fuel debris from within the primary containment vessel of unit 2 at the damaged Fukushima ...

Daiichi Sankyo will present new clinical research across its antibody drug conjugate (ADC) portfolio with more than 25 abstracts across multiple types of cancer at the IASLC 2024 World Conference on ...

On Wednesday, Jefferies, a global investment banking firm, updated its outlook on shares of Daiichi Sankyo Company, Limited (4568:JP) (OTC: DSNKY), raising the price target to JPY7,600 from JPY6,600.

Six late-breaking presentations across lung and breast cancer trials of DXd ADCs, including two Presidential Symposia at WCLC featuring datopotamab deruxtecan data First ever clinical data from ...

Data at WCLC and ESMO showcasing Daiichi Sankyo’s progress towards its goal of creating new standards of care for patients with cancer will include six late-breaking presentations, including two ...

That’s according to Daiichi Sankyo’s UK managing director Manuel Reiberg, whose goal is to make sure the firm is a “responsible pharma company”. Reiberg says this approach rests on two ...

2,3 Patient comorbidities and frailty may unnecessarily affect CVD management. 4,5,6 Daiichi Sankyo remains committed to its promise to continue expanding medical knowledge to support better CV ...

Esaxerenone is under clinical development by Daiichi Sankyo and currently in Phase II for Diabetic Hypertension. According to GlobalData, Phase II drugs for Diabetic Hypertension does not have ...

Pexidartinib hydrochloride is under clinical development by Daiichi Sankyo and currently in Phase II for Sarcomas. According to GlobalData, Phase II drugs for Sarcomas have a 27% phase transition ...

Tokyo Electric Power Company, or TEPCO, on Thursday morning suspended preparatory work for the test retrieval of nuclear fuel debris from one of the reactors at the crippled Fukushima Daiichi ...

Tokyo Electric Power Company, or TEPCO, has postponed a test to retrieve nuclear fuel debris from one of its crippled reactors at the Fukushima Daiichi plant. The utility had planned to begin the ...

In contrast, this performance by the Bach Collegium Japan, conducted by Masaaki Suzuki, left everything to its relatively small number of performers, and the results were simply wondrous. With the ...